课题基金 / 基金详情

TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION

TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION
通过三螺旋形成进行 DNA 定向诱变
批准号:
2700561
负责人:
PETER M GLAZER
金额:
$23.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 1999-04-30

项目摘要

项目成果

PETER M GLAZER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The overal goal of the work is to develop and test novel genetic methods to test the hypothesis that triple helix forming oligonucleotides can be used to deliver site-selective DNA damage and mutation in mammalian cells. The specific aims of the work are to develop new models to study triple helix- mediated mutagenesis (based upon shuttle vector technology), to investigate the physical parameters which affect targeted mutagenesis upon these shuttle vectors in vitro, to examine DNA damage and repair pathways which influence TFO mediated mutation, and finally to extend the work to study TFO mediated mutation in chromosomal genes of the mouse, rather than shuttle vectors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    10198735
  • 项目类别:
  • 资助金额:
    $40.42万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    9804726
  • 项目类别:
  • 资助金额:
    $42.11万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    10414795
  • 项目类别:
  • 资助金额:
    $40.42万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
  • 批准号:
    10274829
  • 项目类别:
  • 资助金额:
    $75.68万
  • 财政年份:
    2018
  • 负责人:
    PETER M GLAZER
  • 依托单位:
国内基金
海外基金
小麦部分同源染色体(homoeologous chromosomes)间的定向重组
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    199万元
  • 批准年份:
    2020
  • 负责人:
    刘宝
  • 依托单位: